Below is a comprehensive archive of press releases from MSF USA. Use the options in the boxes below to filter results based on your preferences.

Topic

As host to both AIDS conference and TPP trade talks this month, Malaysia reportedly vows to reject a TPP trade agreement that harms access to medicines; other countries should follow suit, and Malaysia should be held to its pledge.

More >

The price of first- and second-line ARVs to treat HIV are falling because of increased competition among generic producers, but newer ARVs continue to be priced astronomically high.

More >

New WHO recommendations include earlier antiretroviral therapy for people living with HIV, improved protocols to prevent HIV from being transmitted from mother to child, and regular and more effective monitoring of the amount of virus in people’s blood to ensure treatment is working.

More >

MSF teams in Rakhine State are unable to provide care to many people in need due to ongoing ethnic tensions and threats against MSF staff.

More >

The board of the Global Fund to Fight AIDS, Tuberculosis, and Malaria approved a new funding model, which avoided imposing caps for countries applying for funding. In November, the board will decide on further details pertaining to the new model. 

More >

German pharmaceutical company Bayer is challenging an intellectual property decision in India that allowed more affordable generic drugs to be produced in the interests of public health.

More >

A first-of-its-kind study released today at the International AIDS Conference by MSF maps progress across 23 countries on HIV treatment strategies, tools, and policies needed to increase treatment scale-up. 

More >

As HIV treatment is scaled up in developing countries, the lack of access to viral load monitoring, a method of measuring the level of HIV in a patient that is routinely used in wealthy countries, must be addressed. 

More >

Violence and deep communal divisions in Rakhine State are preventing people from receiving emergency medical treatment.

More >

A landmark patent ruling in India could possibly set a precedent that allows patients in developing countries far greater access to essential medicines.

More >

Pages